Health Canada has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat metabolic dysfunction-associated steatohepatitis (MASH), a severe form of…
Articles by Steve Bryson, PhD
Galangin, a naturally occurring compound found in honey and certain plants, was shown to reduce inflammation and liver injury…
The frequency of primary sclerosing cholangitis (PSC) in people with inflammatory bowel disease (IBD) is lower in Asian countries…
Excessive intake of sorbitol, a type of sugar naturally found in many fruits and used as a sugar substitute, may…
Levels of the metabolite palmitic acid and the protein ACSL1 in the bloodstream can accurately detect the presence and severity…
Liscure Biosciences has launched a Phase 2 clinical trial to test whether its experimental probiotic LB-P8 can improve gut…
Up to three years of treatment with Gilead Sciences‘ Livdelzi (seladelpar) results in sustained reductions in itching and biomarkers…
For infants with biliary atresia, undergoing standard Kasai surgery — a procedure to restore the flow of the digestive…
The most recent assessment of liver stiffness best predicts the future risk of liver disease progression among adults with…
Health Canada has conditionally approved Gilead Sciences’ seladelpar — to be marketed in the country under the brand name…